Quantcast

Latest Biomarker Stories

Biomarkers May Determine How Long Oil Lingers In The Environment
2014-06-13 12:40:41

Brett Smith for redOrbit.com - Your Universe Online While oil from the 2010 Deepwater Horizon oil spill isn’t visible on the surface of the ocean, it continues to wash ashore in the form of small “patties” of oil and sand. In an attempt to analyze and learn about this oil, researchers from the Woods Hole Oceanographic Institution in Massachusetts have developed a system for determining the source and fate of petroleum hydrocarbons in the environment, according to a new report...

2014-06-12 23:09:27

Treatment efficacy for diseases and disorders prioritize the prognosis and diagnosis accuracy; molecular marking being the next step. OMICS Group International is pleased to announce the 6th International Conference on Biomarkers & Clinical Research during August 31 to September 02, 2015 in Toronto, Canada with a view to promote the current research from lab to industry as bio signatures to therapeutic discoveries, to meet the challenges of next generation. Henderson, NV (PRWEB) June...

2014-06-11 23:13:29

New England Peptide and SISCAPA expand commercialization of mass spec biomarker assays. Gardner, MA (PRWEB) June 11, 2014 Today, New England Peptide, Inc. (NEP) and SISCAPA Assay Technologies, Inc. (SAT) announced a collaboration for the manufacture and sale of Stable Isotope Standard (SIS) peptides for use in SISCAPA® protein quantification assays. Under the terms of the agreement, NEP will manufacture peptide standards suitable for use with SAT’s SISCAPA assays. The peptides will...

2014-06-05 08:28:09

Median Overall Survival was 8 Years Longer for Women who were Treated with Therapies Consistent with Caris Molecular Intelligence(TM) Tumor Profiling Prediction and was 2 ½ years Longer after Recurrence IRVING, Texas, June 5, 2014 /PRNewswire/ -- Caris Life Sciences® and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry(TM) at the 50(th) annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago,...

2014-06-04 12:28:56

TUCSON, Ariz., June 4, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and MedImmune, the global biologics research and development arm of AstraZeneca, today announced they are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma. This includes the recently commenced MEDI4736 ATLANTIC trial that will enroll only...

2014-06-04 04:21:45

VIENNA, June 4, 2014 /PRNewswire/ -- AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients. Upon treatment with AD04, effects consistent with disease modification were achieved for at least 18 months in 47% of treated patients. This beneficial effect was dose dependent and more effective in...

2014-06-03 08:32:14

NEW YORK, June 3, 2014 /PRNewswire/ -- Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that Vincent J. O'Neill, M.D., has been appointed as its chief medical officer. Dr. O'Neill has extensive experience in clinical trial design, regulatory issues, and personalized medicine, most recently as global head Personalized of Medicine and Companion Diagnostics at Sanofi. At Sanofi, he defined the personalized medicine...

2014-06-03 08:27:57

LONDON, June 3, 2014 Reportbuyer.com has added a new market research report:Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to...

2014-06-01 08:20:22

Large International Cohort of 17 GI Cancer Types Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 1, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of clinical data at the 50th Annual Meeting of ASCO in which molecular profiling identified numerous potential drug options in patients with various types of gastrointestinal (GI) cancer. Among...

2014-05-31 08:21:15

New DecisionDx-EC multi-analyte test data presented at ASCO 2014 CHICAGO, May 31, 2014 /PRNewswire/ -- Castle Biosciences Inc. today announced study results from its proprietary multi-analyte test DecisionDx-EC, which is designed to determine which patients with esophageal cancer are likely to respond or not respond to standard pre-surgical chemoradiation therapy. The results were reviewed in a poster presentation at the 50(th) Annual Meeting of the American Society of Clinical...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related